Aileen I. Fernandez

Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue

Aileen I. Fernandez, Matthew Liu, Andrew M. Bellizzi et al. · JAMA Oncology · 2022 · 346 citations · Full text

Medicine, Oncology, Pathology +16

Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer

Saman Farahmand, Aileen I. Fernandez, Fahad Ahmed et al. · Modern Pathology · 2021 · 163 citations · Full text

Medicine, Bioinformatics, Oncology +17

Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer

Myrto Moutafi, Charles T. Robbins, Vesal Yaghoobi et al. · Laboratory Investigation · 2022 · 140 citations

Medicine, Molecular Biology, Oncology +13

Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry

Charles T. Robbins, Aileen I. Fernandez, Gang Han et al. · Modern Pathology · 2023 · 97 citations · Full text

Medicine, Oncology, Pathology +11

Discovery of Biomarkers of Resistance to Immune Checkpoint Blockade in NSCLC Using High-Plex Digital Spatial Profiling

Myrto Moutafi, Sandra Martínez-Morilla, Prajan Divakar et al. · Journal of Thoracic Oncology · 2022 · 40 citations · Full text

Medicine, Immunology, Oncology +12